Morie Vandi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Morie Vandi has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Augustus Osborne
Biological Sciences, Njala University, Moyamba, Sierra Leone
4 shared publications - Ibrahim Franklyn Kamara
World Health Organization Country Office, Freetown, Sierra Leone
3 shared publications - Sia Morenike Tengbe
Ministry of Health, Freetown, Sierra Leone
2 shared publications Alren Vandy
World Health Organization Country Office, 21A-B Riverside Drive, Off Kingharman Road, Freetown, Sierra Leone
1 shared publicationAmon Njenga
ICAP at Columbia University, Freetown, Sierra Leone
1 shared publication- Angella Magdalene George
College of Medical Sciences, Njala University, Bo Campus, Sierra Leone
1 shared publication
Latest Publications
- Open Access
- 5 November 2026
- Published by Springer Nature in Infectious Diseases of Poverty
- Vol. 15 (1) , 114
National Ebola preparedness policy architecture and health system readiness in the Democratic Republic of the Congo and Uganda: a scoping review anchored in the 2026 Bundibugyo outbreak
Background: The 2026 Bundibugyo virus disease outbreak was declared in the Democratic Republic of the Congo (DRC) on 15 May 2026, and Uganda confirmed its first case the same day. Neither country had a licensed vaccine or treatment for the virus, yet the outbreak took very different courses in the two. This scoping review maps the evidence on their national preparedness instruments and health system readiness. Methods: We followed the Arksey and O'Malley framework, Joanna Briggs Institute guidance and the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews. National instruments in force at the onset, International Health Regulations evaluations and outbreak documents were sought from the issuing bodies, verified and charted against 52 component requirements in ten dimensions, with operational specificity as an eleventh. A fixed rule assigned each country a four-level descriptor per dimension, and documented outbreak risks were mapped against the gaps. Results: We included 57 sources, 15 of them national instruments. Uganda's instruments addressed 47 of 52 components (90.4%) and the DRC's 38 (73.1%), and 31.7% of Ugandan and 15.2% of Congolese provisions were highly specific. Uganda was rated higher in six dimensions, including surveillance, isolation capacity, displaced populations and accountability, and equal in five. Both were inadequate on cross-border governance, and neither had a Bundibugyo-specific countermeasure provision. In the 2023 Joint External Evaluations the mean indicator score was 2.75 in Uganda and 1.63 in the DRC (paired difference 1.13, 95% confidence interval 0.83 to 1.42). Uganda's outbreak ended with 20 confirmed cases, whereas the DRC had reported 7890 confirmed cases by 23 September. The DRC's response plan of May 2026 was highly specific in 21 of 37 provisions. Conclusions: The two countries differed in standing capacity and in the specificity of their standing instruments. The DRC's highly specific response plan suggests that its gap lay in standing arrangements rather than in response planning. A documentary review cannot establish that these differences caused the different courses of the outbreak. Priorities are surveillance and isolation capacity in the DRC, cross-border governance in both countries and national pathways for investigational Bundibugyo products.
- 5 November 2026
- Published by Springer Nature in Infectious Diseases of Poverty
- Vol. 15 (1) , 114
Open AccessNational Ebola preparedness policy architecture and health system readiness in the Democratic Republic of the Congo and Uganda: a scoping review anchored in the 2026 Bundibugyo outbreak
Background: The 2026 Bundibugyo virus disease outbreak was declared in the Democratic Republic of the Congo (DRC) on 15 May 2026, and Uganda confirmed its first case the same day. Neither country had a licensed vaccine or treatment for the virus, yet the outbreak took very different courses in the two. This scoping review maps the evidence on their national preparedness instruments and health system readiness. Methods: We followed the Arksey and O'Malley framework, Joanna Briggs Institute guidance and the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews. National instruments in force at the onset, International Health Regulations evaluations and outbreak documents were sought from the issuing bodies, verified and charted against 52 component requirements in ten dimensions, with operational specificity as an eleventh. A fixed rule assigned each country a four-level descriptor per dimension, and documented outbreak risks were mapped against the gaps. Results: We included 57 sources, 15 of them national instruments. Uganda's instruments addressed 47 of 52 components (90.4%) and the DRC's 38 (73.1%), and 31.7% of Ugandan and 15.2% of Congolese provisions were highly specific. Uganda was rated higher in six dimensions, including surveillance, isolation capacity, displaced populations and accountability, and equal in five. Both were inadequate on cross-border governance, and neither had a Bundibugyo-specific countermeasure provision. In the 2023 Joint External Evaluations the mean indicator score was 2.75 in Uganda and 1.63 in the DRC (paired difference 1.13, 95% confidence interval 0.83 to 1.42). Uganda's outbreak ended with 20 confirmed cases, whereas the DRC had reported 7890 confirmed cases by 23 September. The DRC's response plan of May 2026 was highly specific in 21 of 37 provisions. Conclusions: The two countries differed in standing capacity and in the specificity of their standing instruments. The DRC's highly specific response plan suggests that its gap lay in standing arrangements rather than in response planning. A documentary review cannot establish that these differences caused the different courses of the outbreak. Priorities are surveillance and isolation capacity in the DRC, cross-border governance in both countries and national pathways for investigational Bundibugyo products.
- Open Access
- 20 October 2026
- Published by Springer Nature in International Journal for Equity in Health
- Vol. 25 (1) , 249
Gender-transformative action as a strategy for health system strengthening: a framework for advancing equity, accountability, and resilience
Gender inequity is embedded in the organisation, financing, leadership, and everyday practice of health systems. It shapes who receives care, who provides
- 20 October 2026
- Published by Springer Nature in International Journal for Equity in Health
- Vol. 25 (1) , 249
Open AccessGender-transformative action as a strategy for health system strengthening: a framework for advancing equity, accountability, and resilience
Gender inequity is embedded in the organisation, financing, leadership, and everyday practice of health systems. It shapes who receives care, who provides
- Open Access
- 3 September 2026
- Published by Springer Nature in Discover Public Health
- Vol. 23 (1) , 1402
A narrative review of progress and lessons from a decade of implementing infection prevention and control in Sierra Leone following the Ebola epidemic
- 3 September 2026
- Published by Springer Nature in Discover Public Health
- Vol. 23 (1) , 1402
Open AccessA narrative review of progress and lessons from a decade of implementing infection prevention and control in Sierra Leone following the Ebola epidemic
- Open Access
- 29 June 2026
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 170, 108940
From Dependency to Leadership: Sierra Leone’s Genomic Response Demonstrates Africa’s Scientific Maturation After the Ebola Outbreak
- 29 June 2026
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 170, 108940
Open AccessFrom Dependency to Leadership: Sierra Leone’s Genomic Response Demonstrates Africa’s Scientific Maturation After the Ebola Outbreak
- Open Access
- 18 June 2026
- Published by Springer Nature in International Journal for Equity in Health
- Vol. 25 (1)
Strengthening women’s leadership in health systems through innovation and intersectionality
Women comprise most of the global health and care workforce, yet they remain underrepresented in leadership across health systems, including in ministries of health, hospitals, academic institutions, humanitarian agencies, and health financing bodies. This imbalance is not only a matter of fairness; it shapes whose expertise is recognised, which priorities are funded, and how health systems respond to inequity, crisis, and exclusion. The problem is particularly acute in fragile and conflict-affected settings, where insecurity, displacement, interrupted education, shrinking civic space, and institutional breakdown further narrow women’s pathways into leadership. This viewpoint argues that strengthening women’s leadership should be treated as a core component of health systems strengthening rather than as a peripheral diversity agenda. It further argues that leadership initiatives must move beyond numerical inclusion to address how authority, legitimacy, and opportunity are distributed across institutions and communities. Drawing on an intersectional lens, the paper examines how gender interacts with ethnicity, caste, class, disability, age, geography, and displacement status to shape who is excluded from leadership pathways and why. It then outlines four practical and adaptable strategies for change: digital mentorship and leadership training platforms, community-based leadership incubators, policy and institutional reform fellowships, and participatory research and advocacy networks. The paper emphasises that leadership development will remain limited unless it is accompanied by reforms to workplace culture, sponsorship, promotion systems, safety, and institutional accountability. Strengthening women’s leadership in health systems is therefore essential not only for representation, but also for building more equitable, trusted, and resilient systems capable of advancing universal health coverage and responding effectively to diverse community needs.
- 18 June 2026
- Published by Springer Nature in International Journal for Equity in Health
- Vol. 25 (1)
Open AccessStrengthening women’s leadership in health systems through innovation and intersectionality
Women comprise most of the global health and care workforce, yet they remain underrepresented in leadership across health systems, including in ministries of health, hospitals, academic institutions, humanitarian agencies, and health financing bodies. This imbalance is not only a matter of fairness; it shapes whose expertise is recognised, which priorities are funded, and how health systems respond to inequity, crisis, and exclusion. The problem is particularly acute in fragile and conflict-affected settings, where insecurity, displacement, interrupted education, shrinking civic space, and institutional breakdown further narrow women’s pathways into leadership. This viewpoint argues that strengthening women’s leadership should be treated as a core component of health systems strengthening rather than as a peripheral diversity agenda. It further argues that leadership initiatives must move beyond numerical inclusion to address how authority, legitimacy, and opportunity are distributed across institutions and communities. Drawing on an intersectional lens, the paper examines how gender interacts with ethnicity, caste, class, disability, age, geography, and displacement status to shape who is excluded from leadership pathways and why. It then outlines four practical and adaptable strategies for change: digital mentorship and leadership training platforms, community-based leadership incubators, policy and institutional reform fellowships, and participatory research and advocacy networks. The paper emphasises that leadership development will remain limited unless it is accompanied by reforms to workplace culture, sponsorship, promotion systems, safety, and institutional accountability. Strengthening women’s leadership in health systems is therefore essential not only for representation, but also for building more equitable, trusted, and resilient systems capable of advancing universal health coverage and responding effectively to diverse community needs.
- Open Access
- 2 January 2026
- Published by Ubiquity Press, Ltd. in Annals of Global Health
- Vol. 92 (1) , 79
Repositioning Primary Health Care in Sierra Leone: From Geographic Access to Effective Coverage
Primary health care (PHC) is central to Sierra Leone’s efforts to achieve universal health coverage. Despite substantial expansion of the peripheral health unit network, improvements in geographic access have not consistently translated into better health outcomes. This viewpoint argues that Sierra Leone must shift its focus from physical access to effective coverage, defined as the proportion of people who receive care of sufficient quality to produce meaningful health gains. Key challenges include persistent out‑of‑pocket expenditure, shortages of salaried health workers, weak service readiness, fragmented vertical programmes, limited digital infrastructure, and variable implementation capacity. Addressing these constraints will require reforms in financing, workforce formalisation, quality improvement, programme integration, and accountability. Strengthening these areas will be essential for ensuring that PHC delivers equitable and measurable health gains for all Sierra Leoneans.
- 2 January 2026
- Published by Ubiquity Press, Ltd. in Annals of Global Health
- Vol. 92 (1) , 79
Open AccessRepositioning Primary Health Care in Sierra Leone: From Geographic Access to Effective Coverage
Primary health care (PHC) is central to Sierra Leone’s efforts to achieve universal health coverage. Despite substantial expansion of the peripheral health unit network, improvements in geographic access have not consistently translated into better health outcomes. This viewpoint argues that Sierra Leone must shift its focus from physical access to effective coverage, defined as the proportion of people who receive care of sufficient quality to produce meaningful health gains. Key challenges include persistent out‑of‑pocket expenditure, shortages of salaried health workers, weak service readiness, fragmented vertical programmes, limited digital infrastructure, and variable implementation capacity. Addressing these constraints will require reforms in financing, workforce formalisation, quality improvement, programme integration, and accountability. Strengthening these areas will be essential for ensuring that PHC delivers equitable and measurable health gains for all Sierra Leoneans.
- Open Access
- 2 January 2026
- Published by Ubiquity Press, Ltd. in Annals of Global Health
- Vol. 92 (1) , 27
Advancing Toward the UNAIDS 95‑95‑95 Targets in Sierra Leone: A Narrative Review of Progress, Persistent Gaps, and Policy Priorities
Background: Sierra Leone, with a low adult HIV prevalence (~1.6–1.7%), faces uneven progress toward the UNAIDS 95‑95‑95 targets, with significant gaps in diagnosis, viral load (VL) coverage, and key population reach. Methods: A narrative review (January 2013–June 2024; final search 30 June 2024) synthesized national reports and peer‑reviewed articles on Sierra Leone’s HIV cascade and systemic determinants. Data focused on diagnosis, treatment, suppression, and cross‑cutting issues (e.g., stigma, supply chain). Results: In 2023, of an estimated 82,000 people living with HIV (PLHIV), 80% (65,600) were diagnosed. Of those diagnosed, 87% (57,072) were on antiretroviral therapy (ART), and 44% of those on ART (25,112) were virally suppressed. VL testing covered 68% of ART patients (38,812), suggesting incomplete coverage may underestimate true population‑level suppression if untested patients are less likely to be suppressed. Key bottlenecks include limited VL platforms, commodity stockouts of antiretrovirals, stigma (especially for female sex workers), adolescent retention gaps, absent drug resistance surveillance, fragmented data systems, and donor‑dependent financing. Conclusions: Progress is tangible but fragile. Prioritizing detection (first 95) through scaled testing, alongside VL network strengthening, differentiated service delivery (e.g., six‑month multi‑month dispensing), stigma monitoring, drug resistance surveillance, and sustainable financing roadmaps, is essential. Targeted research on implementation and cost‑effectiveness will support equitable attainment of HIV 2030 goals.
- 2 January 2026
- Published by Ubiquity Press, Ltd. in Annals of Global Health
- Vol. 92 (1) , 27
Open AccessAdvancing Toward the UNAIDS 95‑95‑95 Targets in Sierra Leone: A Narrative Review of Progress, Persistent Gaps, and Policy Priorities
Background: Sierra Leone, with a low adult HIV prevalence (~1.6–1.7%), faces uneven progress toward the UNAIDS 95‑95‑95 targets, with significant gaps in diagnosis, viral load (VL) coverage, and key population reach. Methods: A narrative review (January 2013–June 2024; final search 30 June 2024) synthesized national reports and peer‑reviewed articles on Sierra Leone’s HIV cascade and systemic determinants. Data focused on diagnosis, treatment, suppression, and cross‑cutting issues (e.g., stigma, supply chain). Results: In 2023, of an estimated 82,000 people living with HIV (PLHIV), 80% (65,600) were diagnosed. Of those diagnosed, 87% (57,072) were on antiretroviral therapy (ART), and 44% of those on ART (25,112) were virally suppressed. VL testing covered 68% of ART patients (38,812), suggesting incomplete coverage may underestimate true population‑level suppression if untested patients are less likely to be suppressed. Key bottlenecks include limited VL platforms, commodity stockouts of antiretrovirals, stigma (especially for female sex workers), adolescent retention gaps, absent drug resistance surveillance, fragmented data systems, and donor‑dependent financing. Conclusions: Progress is tangible but fragile. Prioritizing detection (first 95) through scaled testing, alongside VL network strengthening, differentiated service delivery (e.g., six‑month multi‑month dispensing), stigma monitoring, drug resistance surveillance, and sustainable financing roadmaps, is essential. Targeted research on implementation and cost‑effectiveness will support equitable attainment of HIV 2030 goals.